coding breast cancer

Release time ：Dec-17,2024

Encoded breast cancer typically refers to breast cancer types identified through genetic methods, often linked to specific genetic mutations, such as BRCA1 and BRCA2. These mutations can significantly elevate an individual's risk of developing breast cancer.

In our detailed analysis, we first explore the function of the BRCA1 and BRCA2 genes. These are tumor suppressor genes that normally repair cellular DNA damage. However, when these genes mutate, the DNA damage cannot be effectively repaired, potentially leading to abnormal cell proliferation and tumor formation. Statistics show that women with BRCA1 or BRCA2 mutations face an up to 87% lifetime risk of breast cancer, significantly higher than the general population's 12% risk. Moreover, these mutations may also increase the risk of ovarian cancer and other cancers.

For individuals with a family history or other high-risk factors, genetic counseling and testing are recommended to assess cancer risk. Positive test results may warrant more frequent screening, such as mammography (breast X-ray) and magnetic resonance imaging (MRI), or discussions with doctors about other risk management strategies, including prophylactic surgery. Crucially, decisions regarding treatment or prevention should be made under the guidance of healthcare professionals to ensure personalized and optimal health management plans.